Clinical Trial Update: A Phase 1 Study Evaluating CPI-0610 in Patients With Progressive Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 study of CPI-0610 in patients with progressive lymphoma has completed. The update notes the trial status as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• CPI-0610 (CPI-0610)

Snippet

Sponsor: Constellation Pharmaceuticals | Conditions: Lymphoma | Phase 1 | Status: COMPLETED